Long COVID: Costs for the German economy and health care and pension system von Gandjour, Afschin

Volltext

Determining the societal value of a prospective drug for ME/CFS in Germany von Gandjour, Afschin

Volltext

Optimal allocation of scarce PCR tests during the COVID-19 pandemic von Gandjour, Afschin

Volltext

Modelling the cost-effectiveness and budget impact of pay-for-performance programs in health care von Gandjour, Afschin

Volltext

Inclusion of phase III clinical trial costs in health economic evaluations von Gandjour, Afschin

Volltext

Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG von Gandjour, Afschin

Volltext

Value-based pricing of cognitive behavioral therapy for depression in primary care: an economic evaluation von Gandjour, Afschin

Volltext

COVID-19 and the forgone health benefits of elective operations von Gandjour, Afschin

Volltext

The clinical and economic value of a successful shutdown during the SARS-CoV-2 pandemic in Germany von Gandjour, Afschin

Volltext

Was EU's COVID-19 vaccine procurement strategy irrational? A re-analysis based on cost-effectiveness considerations von Gandjour, Afschin

Volltext

The price of curing cancer von Gandjour, Afschin

Volltext

Benefits, risks, and cost-effectiveness of COVID-19 self-tests from a consumer's perspective von Gandjour, Afschin

Volltext

A parsimonious model to validate cost-effectiveness analyses on preventive health care von Gandjour, Afschin

Volltext

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency von Gandjour, Afschin

Volltext

Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results von Gandjour, Afschin

Volltext

Trends in rates of orthopedic surgery in Germany: the good, the bad, and the ugly von Gandjour, Afschin

Volltext

Costs of patients with chronic kidney disease in Germany von Gandjour, Afschin, Armsen, Wencke, Wehmeyer, Wolfgang, Multmeier, Jan, Tschulena, Ulrich

Volltext

Nephron overload as a therapeutic target to maximize kidney lifespan von Luyckx, Valerie A., Rule, Andrew D., Tuttle, Katherine R., Delanaye, Pierre, Liapis, Helen, Gandjour, Afschin, Romagnani, Paola, Anders, Hans-Joachim

Volltext

Strategy for the “New Normal” of Life With COVID von Gandjour, Afschin

Volltext

Negative Drug Pricing in the Context of Cost-Effectiveness Analysis: A Consistency Examination von Gandjour, Afschin

Volltext